For instance, in glioblastoma and sporadic colorectal cancer, MGMT and MLH1 promoter methylation analyses through methylation‐sensitive pyrosequencing are employed for diagnostic and prognostic purposes.283, 284. The gene discussed is MGMT; the disease is glioblastoma.